Esco’s $200M series A provides glimpse into burgeoning Singapore ecosystem

Look for Singapore’s Esco to be an active M&A player in Asia’s tools market now that it’s raised a $200 million series A crossover round led by Vivo and Novo Holdings, which gives the company dry powder to further its ambition of becoming a tools aggregator in the region. 

The financing is the latest sign that Singapore’s life sciences ecosystem is rapidly coming of age, with deep pocketed global investors backing the round — one of which just established an office in Singapore — and companies such as BioNTech SE (NASDAQ:BNTX) picking the island nation as home to manufacturing hubs...